Overview

The Research of Standard Diagnosis and Treatment for HSPN in Children

Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
0
Participant gender:
All
Summary
This study is performed to evaluate the efficacy and safety of various measures in the treatment of HSPN in children.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nanjing Children's Hospital
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Cyclophosphamide
Enzyme Inhibitors
Leflunomide
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Mycophenolate mofetil
Mycophenolic Acid
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Prednisone
Criteria
Inclusion Criteria:

- Renal biopsy proved HSPN Proteinuria ≥ 50 mg/kg/d

Exclusion Criteria:

- The children with congenital diseases Proteinuria < 50 mg/kg/d